当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Amanda I. Silverio, Matthew C. Squires and Julia C. Knight
Substance use Disorder (SUD) is a common disorder in the United States and is frequently comorbid with depression. Electroconvulsive therapy (ECT) is the most effective treatment for depression. However, literature offers an unclear picture of whether patients with comorbid SUD are less likely to receive, or benefit from, ECT. Limited data exists regarding alcohol use disorder in ECT, while the impact of other types of SUD in ECT patients remains mostly unexplored. In this article, we review the current literature base for SUD in ECT patients and present a case where ECT was used successfully in a patient with bipolar affective disorder, current episode depressed, as well as co-morbid alcohol use disorder and opioid use disorder, in sustained remission on medication assisted therapy. Further research into ECT utilization patterns and response rates for patients with opioid use disorder is indicated.